Compound information
- Natural Products
- ZC1802571
- Molecular Formula
- C21H22O6
- Molecular Weight
- 370.141638424 g/mol
- Structure
-
- IUPAC Name
- (E)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hept-1-ene-3,5-dione
- InChI
- InChI=1S/C21H22O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3,5-7,9-12,24-25H,4,8,13H2,1-2H3/b7-3+
- InChI Key
- MUYJSOCNDLUHPJ-XVNBXDOJSA-N
- SMILES
- COc1cc(/C=C/C(=O)CC(=O)CCc2ccc(O)c(OC)c2)ccc1O
- Source
- ZINC000013412576
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 93.06 Å2 | LogP | 2.432 |
LogS | -5.143 | LogD | 2.828 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.032 | Pgp substrate | 0.002 |
HIA | 0.96 | F20 % | 0.99 |
F30 % | 0.969 | Caco-2 | -4.77 |
MDCK | -4.951 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.039 | PPB | 92.998 |
VD | 0.827 | Fu | 1.335 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.686 | CYP1A2 substrate | 0.587 |
CYP2A6 substrate | 0.413 | CYP2B6 substrate | 0.663 |
CYP2C19 inhibitor | 0.236 | CYP2C19 substrate | 0.718 |
CYP2C8 substrate | 0.778 | CYP2C9 inhibitor | 0.802 |
CYP2C9 substrate | 0.144 | CYP2D6 inhibitor | 0.642 |
CYP2D6 substrate | 0.56 | CYP2E1 substrate | 0.17 |
CYP3A4 inhibitor | 0.857 | CYP3A4 substrate | 0.064 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.985 | CL | 15.442 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.026 | Hepatotoxicity | 0.358 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.036 |
FDAMDD | 0.652 | Skin Sensitization | 0.996 |
Carcinogenicity | 0.397 | Eye Corrosion | 0.001 |
Eye Irritation | 0.952 | Respiratory Toxicity | 0.429 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.0 | IGC50 | 5.38 |
LC50FM | 5.521 | LC50DM | 4.653 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.51 | NR-AR-LBD | 0.905 |
NR-AhR | 0.722 | NR-Aromatase | 0.183 |
NR-ER | 0.877 | NR-ER-LBD | 0.689 |
NR-PPAR-gamma | 0.955 | SR-ARE | 0.556 |
SR-ATAD5 | 0.914 | SR-HSE | 0.601 |
SR-MMP | 0.87 | SR-p53 | 0.689 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.